Article
The CYP2C19 genotype and the use of oral contraceptives influence the pharmacokinetics of carisoprodol in healthy human subjects.
European journal of clinical pharmacology - 1 Aug 2005
Bramness Jørgen G, Skurtveit Svetlana, Gulliksen Margaretha, Breilid Harald, Steen Vidar M, Mørland Jørg
Abstract excerpt
AIMS: The aim of the present study was to investigate if subjects with one normal and one non-functional CYP2C19 allele (intermediate metabolizers; IMs) metabolized carisoprodol differently than individuals with two normal CYP2C19 alleles (extensive metabolizers; EMs) We also wanted to investigate whether the use of oral contraceptives influences the metabolism of carisoprodol in EMs and IMs. Impairing effects on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
